Newsroom - BioNTech
网页Welcome to the BioNTech Newsroom. In this section you can find a variety of media materials and useful information to download. Media Downloads. Conference "Working Together to Promote Vaccine Equity for Africa", December 18, 2023. Africa Vaccine Equity Conference 1. Africa Vaccine Equity Conference 2. Africa Vaccine Equity Conference 3.
BioNTech
网页We strive to exploit the full potential of the body’s immune system by combining powerful new therapeutic mechanisms and a diverse array of biological targets to successfully help address cancer, infectious diseases and other serious diseases.
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
网页2021年8月23日 · NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for COMIRNATY ® (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 16 years of age and older. COMIRNATY is the first COVID ...
Pfizer and BioNTech Announce Positive Topline Data for mRNA …
网页2023年10月26日 · NEW YORK & MAINZ, GERMANY--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive topline results from a Phase 1/2 study (NCT05596734) evaluating the safety, tolerability and immunogenicity of mRNA-based combination vaccine candidates for influenza and COVID-19 among healthy adults 18 to 64 years of ...
Pfizer and BioNTech Advance Next-Generation COVID-19 …
网页2022年11月16日 · NEW YORK and MAINZ, GERMANY, NOVEMBER 16, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a Phase 1 study to evaluate the safety, tolerability and immunogenicity of a next generation COVID-19 vaccine candidate that aims to enhance SARS-CoV-2 T cell responses and potentially ...
Jefferies upgrades BioNTech SE (BNTX) to a Buy - Markets Insider
网页6 天之前 · Sep. 16, 2024, 11:35 PM. Jefferies analyst Akash Tewari upgraded BioNTech SE (BNTX – Research Report) to a Buy today and set a price target of $150.00. The company’s shares closed yesterday at...
US FDA authorizes Pfizer-BioNTech and Moderna's updated …
网页Sept 11 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday authorized updated COVID-19 vaccines from Pfizer (PFE.N) /BioNTech (22UAy.DE) and Moderna (MRNA.O) that target a recently...
BioNTech Announces Positive Topline Phase 2 Results for mRNA ...
网页2024年7月30日 · BioNTech SE. Primary endpoint met in a Phase 2 trial evaluating the investigational mRNA immunotherapy BNT111 in combination with the PD-1 checkpoint inhibitor cemiplimab. Data demonstrated a...
BioNTech SE (BNTX) Latest Stock News & Headlines - Yahoo …
网页Get the latest BioNTech SE (BNTX) stock news and headlines to help you in your trading and investing decisions.
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
网页2024年8月22日 · The updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID...